Literature DB >> 6803820

Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration.

S Dhillon, A Richens.   

Abstract

1 The pharmacokinetics of diazepam following intravenous administration have been investigated in six normal volunteers and nine epileptic patients receiving chronic antiepileptic drug therapy. 2 After intravenous administration, serum diazepam levels declined biexponentially in all subjects. The elimination half-life was significantly shorter and the plasma clearance significantly higher in the patients than in the normal volunteers. 3 Serum N-desmethyldiazepam levels were higher and the time to peak serum concentration was earlier in the epileptic patients than in the controls. 4 It is suggested that the metabolism of diazepam is induced in patients treated with enzyme inducing antiepileptic drugs, although a protein binding interaction between valproic acid and diazepam may contribute to the higher plasma clearance in the epileptic patients taking sodium valproate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6803820      PMCID: PMC1401936          DOI: 10.1111/j.1365-2125.1981.tb01317.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Lack of hepatic enzyme inducing effect of sodium valproate.

Authors:  J Oxley; A Hedges; K A Makki; A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

2.  Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood plasma by gas-liquid chromatography.

Authors:  D M Rutherford
Journal:  J Chromatogr       Date:  1977-07-21

3.  The comparative enzyme-inducing properties of antiepileptic drugs [proceedings].

Authors:  E Perucca; A Hedges; K Makki; S Hebdige; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

4.  Effect of phenobarbital on the in vitro metabolism of diazepam in several animal species.

Authors:  F Marcucci; R Fanelli; E Mussini; S Garattini
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

5.  Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.

Authors:  I Sjöholm; B Ekman; A Kober; I Ljungstedt-Påhlman; B Seiving; T Sjödin
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

6.  Serum protein binding of diazepam and its displacement by valproic acid in vitro.

Authors:  S Dhillon; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

7.  Plasma protein binding of diazepam after a single dose of sodium oleate.

Authors:  W A Colburn; M Gibaldi
Journal:  J Pharm Sci       Date:  1978-06       Impact factor: 3.534

Review 8.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

9.  Diazepam disposition determinants.

Authors:  D J Greenblatt; M D Allen; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

10.  The effect of enzyme induction on diazepam metabolism in man.

Authors:  E E Ohnhaus; B K Park; J P Colombo; P Heizmann
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

View more
  7 in total

1.  Evaluation of the pharmacokinetic interaction between diazepam and ACC-9653 (a phenytoin prodrug) in healthy male volunteers.

Authors:  E K Hussey; G E Dukes; J A Messenheimer; K L Brouwer; K H Donn; T F Krol; L J Hak
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

Review 2.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Authors:  S Jawad; A Richens; J Oxley
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 5.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

6.  The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms.

Authors:  Selma Sahin; Leslie Z Benet
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

7.  Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus.

Authors:  Lawrence C Ku; Christoph P Hornik; Ryan J Beechinor; James M Chamberlain; Jeffrey T Guptill; Barrie Harper; Edmund V Capparelli; Karen Martz; Ravinder Anand; Michael Cohen-Wolkowiez; Daniel Gonzalez
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.